| Q36800277 | Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design |
| Q34358833 | Characterization of a novel murine retrovirus mixture that facilitates hematopoiesis |
| Q33859375 | Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome |
| Q36468987 | Feline Leukaemia Virus: Generation of Pathogenic and Oncogenic Variants |
| Q24647823 | Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas |
| Q45784421 | In vivo selection of long terminal repeat alterations in feline leukemia virus-induced thymic lymphomas. |
| Q33646004 | Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2. |
| Q46986901 | Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14. |
| Q33639086 | Sequence-specific and/or stereospecific constraints of the U3 enhancer elements of MCF 247-W are important for pathogenicity. |
| Q40108493 | Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. |
| Q37544858 | Substitution of leucine for isoleucine in a sequence highly conserved among retroviral envelope surface glycoproteins attenuates the lytic effect of the Friend murine leukemia virus |